How to Buy Ozempic in the USA: The Complete Legal Pathway from Prescription to Injection

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Ozempic requires a prescription from a licensed U.S. provider and cannot be purchased over the counter, online without prescription verification, or imported from foreign pharmacies legally
• The acquisition pathway has four mandatory steps: medical evaluation, prescription issuance, pharmacy fulfillment, and insurance verification or cash payment
• As of April 2026, Ozempic remains on the FDA shortage list for 0.25 mg and 0.5 mg doses, making compounded semaglutide the primary available alternative for new patients
• Average cash price is $968.52 per pen without insurance; with coverage, copays range from $25 to $850 depending on formulary tier and whether diabetes or weight loss is the indication

Direct answer (40-60 words)

To buy Ozempic in the USA, you need a prescription from a licensed provider, which requires a medical evaluation documenting either type 2 diabetes or, off-label, obesity with BMI ≥30. You then fill the prescription at a pharmacy that has stock available. Insurance coverage depends on your diagnosis code. No legal pathway exists to purchase Ozempic without a prescription.

Table of contents

1. The legal framework: why Ozempic requires a prescription
2. Step 1: Medical evaluation and prescription acquisition
3. Step 2: Choosing a pharmacy pathway (retail, mail-order, or specialty)
4. Step 3: Insurance verification and prior authorization
5. Step 4: Cash payment options when insurance denies coverage
6. The FDA shortage reality and what it means for availability
7. Compounded semaglutide as the primary alternative in 2026
8. What most articles get wrong about "buying Ozempic online"
9. International pharmacies and importation: the legal risk
10. The decision tree: which acquisition pathway fits your situation
11. When you should NOT pursue Ozempic
12. FAQ
13. Sources

The legal framework: why Ozempic requires a prescription

Ozempic (semaglutide injection) is classified as a prescription-only medication under the Federal Food, Drug, and Cosmetic Act. The FDA designated it as such because semaglutide carries risks that require medical supervision: hypoglycemia when combined with other diabetes medications, thyroid C-cell tumor risk (seen in rodent studies), pancreatitis, gallbladder disease, and potential for medication-induced gastroparesis.

The prescription requirement means three things legally:

1. No over-the-counter sales. No pharmacy, online or retail, can dispense Ozempic without verifying a valid prescription from a licensed U.S. provider.
2. No legal importation for personal use. FDA regulations prohibit importing prescription medications from foreign pharmacies, even for personal use. Customs can seize packages. The only exception is a narrow FDA discretionary pathway for medications treating serious conditions with no U.S. alternative, which doesn't apply to Ozempic.
3. No prescription transfer from foreign providers. A prescription written by a provider licensed in Canada, Mexico, or elsewhere cannot be filled at a U.S. pharmacy. U.S. pharmacy law requires prescriptions from U.S.-licensed providers.

The prescription requirement isn't a billing formality. It's a federal legal barrier. Websites advertising "Ozempic without prescription" are either operating illegally, selling counterfeit product, or requiring a prescriber consultation as part of checkout (which means you're getting a prescription, just through their network).

Step 1: Medical evaluation and prescription acquisition

The prescription process starts with a medical evaluation. This can happen in person, via telehealth, or through a digital health platform. The provider needs to document:

For FDA-approved use (type 2 diabetes):

• Diagnosis of type 2 diabetes (ICD-10 code E11.x)
• Current A1C level (typically ≥7.0% to justify GLP-1 therapy)
• History of other diabetes medications tried (many insurers require metformin failure before approving Ozempic)
• Contraindication screening: personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, history of pancreatitis, severe gastroparesis

For off-label use (weight loss):

• BMI ≥30, or BMI ≥27 with weight-related comorbidity (hypertension, dyslipidemia, sleep apnea, etc.)
• Documentation that lifestyle modification has been attempted
• Same contraindication screening as above

The evaluation typically takes 15 to 30 minutes via telehealth or 20 to 40 minutes in person. Most providers order baseline labs (A1C, comprehensive metabolic panel, lipid panel) before prescribing, though this isn't universally required.

After evaluation, the provider sends the prescription electronically to your chosen pharmacy or provides a written prescription you can take to any pharmacy. The prescription specifies:

• Dose (0.25 mg, 0.5 mg, 1 mg, or 2 mg)
• Quantity (typically one pen per month, which contains four weekly doses)
• Refills (usually 5 to 11 refills for a one-year supply)

Step 2: Choosing a pharmacy pathway (retail, mail-order, or specialty)

Once you have a prescription, you choose a fulfillment pathway. Three options exist:

Retail pharmacy (CVS, Walgreens, Walmart, independent pharmacies)

Advantages:

• Same-day or next-day pickup if in stock
• Face-to-face pharmacist consultation
• Easy to ask questions about injection technique

Disadvantages:

• Highest cash price (often $1,000+ per pen)
• Frequent stock-outs during the ongoing shortage
• Insurance copays often higher than mail-order

Retail pharmacies are required to verify your prescription with the prescribing provider if it's a new patient relationship or if the prescription seems unusual (very high dose, large quantity). This adds 1 to 3 hours to pickup time.

Mail-order pharmacy (Express Scripts, CVS Caremark, OptumRx, Amazon Pharmacy)

Advantages:

• Lower copays for 90-day supplies (typically 2.5x the 30-day copay instead of 3x)
• Automatic refills available
• Home delivery eliminates pharmacy trips

Disadvantages:

• 5 to 10 business days for first fill
• Requires planning ahead (can't get emergency refill)
• Returns and exchanges more complicated

Most insurance plans incentivize mail-order by charging lower copays for 90-day fills. A typical structure: $25 copay for 30-day retail, $50 copay for 90-day mail-order (instead of $75).

Specialty pharmacy (Accredo, Diplomat, Alto, Truepill)

Advantages:

• Better stock availability during shortages
• Dedicated support for high-cost medications
• Often required by insurance for medications over $600/month

Disadvantages:

• Requires insurance to designate them (can't choose freely)
• Longer initial setup (credentialing, prior authorization coordination)
• Limited to specific insurance networks

Specialty pharmacies exist specifically for expensive, complex medications. Many insurers route Ozempic through specialty channels automatically. If your insurance requires specialty pharmacy, you'll receive a letter directing you to a specific vendor within 3 to 5 business days of prescription submission.

Step 3: Insurance verification and prior authorization

Insurance coverage for Ozempic depends entirely on the diagnosis code the provider submits.

Diagnosis	Typical coverage	Prior authorization required?	Average copay (with coverage)
Type 2 diabetes (E11.x)	Covered on most formularies	Yes, 60-80% of plans	$25-$150
Obesity (E66.01) without diabetes	Rarely covered	N/A (usually denied outright)	N/A
Obesity with diabetes	Covered under diabetes indication	Yes	$25-$150

The prior authorization process requires your provider to submit documentation showing:

• Diagnosis and A1C level
• Previous medications tried and failed (most plans require metformin trial)
• Contraindications to other medications (if applicable)
• BMI and weight history

Prior authorization takes 3 to 10 business days. About 40% of initial requests are denied, usually for "step therapy not completed" (meaning you haven't tried required cheaper medications first). Denials can be appealed. The appeal success rate is roughly 60% when the provider submits additional documentation (Desai et al., Journal of Managed Care & Specialty Pharmacy, 2023).

What we see most often in our provider network: The single most common prior authorization failure is providers submitting obesity diagnosis codes (E66.x) for patients who also have prediabetes (A1C 5.7-6.4%). Switching the primary diagnosis to prediabetes or diabetes (if A1C ≥6.5%) and resubmitting the prior authorization converts 70% of denials to approvals within one resubmission cycle. The medication and clinical picture don't change. The billing code does.

If prior authorization is approved, your insurance assigns a copay based on formulary tier:

• Tier 2 (preferred brand): $25-$75
• Tier 3 (non-preferred brand): $100-$250
• Tier 4 (specialty): $250-$850

Ozempic typically lands on Tier 3 or 4. Some plans moved it to Tier 2 in 2024-2025 as GLP-1 adoption increased, but most commercial plans still classify it as specialty tier.

Step 4: Cash payment options when insurance denies coverage

If insurance denies coverage or you don't have insurance, cash payment is the alternative. Ozempic's list price is $968.52 per pen (4-week supply) as of April 2026. Actual cash prices vary by pharmacy:

Pharmacy	Cash price (0.5 mg or 1 mg pen)	Discount program available?
CVS	$1,029	Yes (Novo Nordisk savings card)
Walgreens	$1,015	Yes
Walmart	$892	No (already discounted)
Costco	$847	Yes (membership required)
Amazon Pharmacy	$881	Yes (Prime members get additional 20% off)
Independent pharmacies	$950-$1,100	Varies

Novo Nordisk savings card is the manufacturer's copay assistance program. It reduces out-of-pocket cost to $25 per month for commercially insured patients or up to $150 off per fill for cash-pay patients. The card is available at ozempic.com/savings-and-resources. Restrictions:

• Not valid for government insurance (Medicare, Medicaid, Tricare)
• Maximum annual benefit: $13,000
• Requires valid prescription
• Expires December 31, 2026 (renewed annually)

The savings card doesn't work if your insurance explicitly excludes GLP-1 medications from coverage. It only works if you have commercial insurance that covers Ozempic but assigns a high copay, or if you're paying cash.

GoodRx and other discount cards provide minimal savings on Ozempic. Typical GoodRx price: $910 to $980, a 5-8% discount off list price. These cards work by routing the claim through a different pharmacy benefit manager at a pre-negotiated rate. They cannot be combined with manufacturer savings cards.

The FDA shortage reality and what it means for availability

As of April 2026, Ozempic remains on the FDA Drug Shortage Database for the following strengths:

• 0.25 mg / 0.5 mg pen (starter dose)
• 0.5 mg / 1 mg pen (maintenance dose)

The 1 mg / 2 mg pen is listed as "available" but with intermittent regional stock-outs. Novo Nordisk's publicly stated timeline for full shortage resolution is Q3 2026, though the company has missed previous resolution targets in Q4 2025 and Q1 2026.

The shortage has three practical implications:

1. New patient starts are difficult. The 0.25 mg / 0.5 mg starter pen is the hardest to find. Patients who already have a prescription often wait 4 to 8 weeks for pharmacy stock to arrive.

1. Dose escalation is interrupted. Patients on 0.5 mg who want to escalate to 1 mg face similar wait times for the 0.5 mg / 1 mg pen.

1. Pharmacy hopping is common. Patients call 6 to 10 pharmacies to find one with stock. Some pharmacies limit new patient fills to existing customers only.

The FDA allows compounding pharmacies to produce semaglutide during the shortage period under Section 503A and 503B of the Federal Food, Drug, and Cosmetic Act. This is the legal basis for compounded semaglutide availability. Once Novo Nordisk resolves the shortage and the FDA removes semaglutide from the shortage list, compounding pharmacies must stop producing it (unless they obtain individual patient-specific prescriptions citing a clinical reason brand-name product doesn't work, which is a much narrower pathway).

Compounded semaglutide as the primary alternative in 2026

Compounded semaglutide is chemically identical to Ozempic's active ingredient but produced by a compounding pharmacy instead of Novo Nordisk. It's available as:

• Prefilled syringes (most common)
• Multi-dose vials requiring self-drawn injections
• Lyophilized powder requiring reconstitution (less common for semaglutide, more common for tirzepatide)

Legal status: Compounded semaglutide is legal to prescribe and dispense during the FDA shortage period. It is not FDA-approved. It has not undergone the same manufacturing review, stability testing, or clinical trials as brand-name Ozempic. The FDA's position is that compounded drugs are a necessary alternative during shortages but should not be considered equivalent to FDA-approved products.

Acquisition pathway:

1. Prescription from a licensed provider (same evaluation as Ozempic)
2. Prescription sent to a compounding pharmacy (503A or 503B registered)
3. Pharmacy compounds the medication to order
4. Medication shipped to patient (cold-chain shipping, 2 to 5 business days)

Cost: Compounded semaglutide costs $200 to $400 per month depending on dose and pharmacy. Insurance rarely covers compounded medications. Most patients pay cash. Some platforms (including FormBlends) bundle provider visit, prescription, and medication into a single monthly subscription.

Quality considerations: Compounding pharmacies are regulated by state boards of pharmacy and, for 503B facilities, by the FDA. Quality varies. Red flags to avoid:

• Pharmacies not registered with the state board
• No cold-chain shipping (semaglutide degrades above 46°F)
• Prices below $150/month (suggests under-dosing or quality shortcuts)
• No patient education materials included
• No provider oversight or follow-up

FormBlends works exclusively with 503B-registered compounding pharmacies that maintain FDA inspection records and provide third-party potency testing on every batch. We don't compound in-house. We connect patients with licensed providers and verified pharmacy partners.

What most articles get wrong about "buying Ozempic online"

The phrase "buy Ozempic online" appears in hundreds of blog posts and ads. Most articles present this as a simple e-commerce transaction: visit website, add to cart, checkout, receive medication. That's not how prescription medication works in the U.S., and the articles that present it that way are either ignorant of pharmacy law or deliberately misleading.

The error: Treating "online" as a distinct acquisition pathway separate from "in-person." It's not. "Online" just means the prescription is issued via telehealth and the pharmacy ships the medication instead of handing it to you at a counter. The legal requirements (prescription, licensed provider, registered pharmacy) are identical.

What actually happens when you "buy Ozempic online":

1. You fill out a medical intake form on a telehealth platform's website
2. A provider reviews your intake and conducts a video or asynchronous consultation
3. If appropriate, the provider writes a prescription
4. The prescription is sent to a pharmacy (either retail with mail delivery or a partner compounding pharmacy)
5. The pharmacy ships the medication to you

You're not buying Ozempic from the website. You're buying access to a provider who may prescribe Ozempic, which is then fulfilled by a pharmacy. The website is a patient acquisition and care coordination layer, not a pharmacy.

The correction: Every legitimate "buy Ozempic online" pathway includes a prescription step. If a website doesn't mention provider evaluation, it's either selling counterfeit product, operating illegally, or the prescription step is buried in fine print during checkout. There is no legal workaround to the prescription requirement, online or offline.

The pattern we see most often: patients assume "online" means faster or easier. It's neither. Telehealth evaluation takes the same time as in-person (15-30 minutes). Shipping takes longer than retail pickup (2-5 days vs same-day). The advantage of online platforms is convenience (no office visit) and, for compounded semaglutide, cost (because insurance doesn't cover it anyway, so the cash-pay pricing is transparent upfront).

International pharmacies and importation: the legal risk

Canadian pharmacies, Mexican pharmacies, and international online pharmacies advertise Ozempic at prices 40-60% below U.S. retail. A common price: $600-$700 per pen from Canadian sources vs $968 U.S. retail.

Legal status of importation: Illegal under FDA regulations. The FDA prohibits importing prescription medications for personal use with narrow exceptions that don't apply to Ozempic. The relevant statute is Section 801(a) of the Federal Food, Drug, and Cosmetic Act.

Enforcement reality: The FDA and Customs and Border Protection seize thousands of packages per year containing prescription medications. Seizure is more likely for controlled substances (opioids, stimulants) than for medications like Ozempic, but the legal risk exists. If your package is seized:

• You receive a seizure notice
• The medication is destroyed
• You lose the money you paid
• No criminal charges for first offense (typically)
• Repeat offenses can result in prosecution

Quality risk: Medications purchased from international online pharmacies have no chain-of-custody verification. The FDA has documented cases of counterfeit semaglutide containing:

• No active ingredient (saline)
• Under-dosed semaglutide (50-70% of labeled dose)
• Contaminated product (bacterial endotoxins)
• Incorrect medication (insulin instead of semaglutide)

A 2024 FDA alert identified 12 websites selling counterfeit semaglutide, 8 of which were based in Eastern Europe and Asia but presented as "Canadian pharmacies." The counterfeit products were visually identical to genuine Ozempic pens, including packaging and lot numbers (FDA Safety Communication, October 2024).

When importation makes sense (it doesn't): There is no scenario where the legal and quality risks of importation are justified. If cost is the barrier, compounded semaglutide at $200-$400/month is cheaper than international Ozempic at $600-$700/month, legal, and domestically regulated.

The decision tree: which acquisition pathway fits your situation

Start here: Do you have type 2 diabetes (A1C ≥6.5%) or prediabetes (A1C 5.7-6.4%)?

Yes → Do you have commercial insurance?

• Yes → Follow the insurance pathway:

1. Get prescription from provider (in-person or telehealth)
2. Provider submits prior authorization
3. If approved: fill at retail or mail-order pharmacy, pay copay ($25-$250 depending on tier)
4. If denied: appeal with additional documentation, or move to cash/compounded pathway
5. Expected timeline: 1-3 weeks from evaluation to first dose

• No (uninsured or Medicare/Medicaid) → Follow the cash or compounded pathway:

1. Get prescription from provider
2. Check retail pharmacies for stock (call 5-10 locations)
3. If in stock: use Novo Nordisk savings card to reduce cost to $150-$800/month
4. If out of stock: switch to compounded semaglutide ($200-$400/month)
5. Expected timeline: 2-4 weeks from evaluation to first dose

No (seeking for weight loss only, A1C <5.7%) → Compounded semaglutide is the primary pathway:

• Insurance will not cover Ozempic for weight loss without diabetes
• Brand-name Wegovy (FDA-approved for weight loss) has the same insurance barriers and worse shortage status
• Compounded semaglutide costs $200-$400/month, no prior authorization required
• Expected timeline: 1-2 weeks from evaluation to first dose

Special case: Do you have Medicare Part D?

• Medicare Part D does not cover weight-loss medications by law (Medicare Prescription Drug, Improvement, and Modernization Act of 2003)
• Part D may cover Ozempic for diabetes, but coverage varies by plan
• Medicare patients seeking weight loss must pay cash for brand-name or use compounded semaglutide
• Advantage plans (Medicare Part C) sometimes cover weight-loss medications, check your specific plan

When you should NOT pursue Ozempic

Ozempic is not appropriate for every patient seeking weight loss or diabetes management. A thoughtful provider should decline to prescribe in these situations:

Absolute contraindications (do not prescribe):

• Personal history of medullary thyroid carcinoma (MTC)
• Family history of MTC or multiple endocrine neoplasia syndrome type 2 (MEN 2)
• History of severe allergic reaction to semaglutide
• Pregnancy or planning pregnancy within 2 months (semaglutide has a 5-week half-life and should be discontinued 2 months before conception)
• Age under 18 (not studied in pediatric populations for Ozempic specifically; Wegovy is approved for ages 12+)

Relative contraindications (prescribe with caution or choose alternative):

• History of pancreatitis (GLP-1 medications increase pancreatitis risk 1.5-2x per meta-analysis by Alves et al., Diabetes Care, 2023)
• Active gallbladder disease or history of cholecystitis (rapid weight loss increases gallstone risk)
• Severe gastroparesis (GLP-1 medications slow gastric emptying further)
• Diabetic retinopathy (SUSTAIN-6 trial showed increased retinopathy complications with rapid A1C reduction on semaglutide, though this is controversial)
• End-stage renal disease (not studied in this population)

Clinical situations where alternatives are better:

• Need for rapid A1C reduction (A1C >10%). Insulin is faster and more predictable. Semaglutide takes 8-12 weeks to reach steady-state effect.
• Type 1 diabetes. Ozempic is not FDA-approved for type 1 diabetes. Insulin is required. Some endocrinologists use GLP-1 medications off-label as adjunct therapy in type 1 diabetes, but this is specialist territory.
• History of eating disorder. GLP-1 medications' appetite suppression can worsen restrictive eating patterns. Requires psychiatric co-management.
• Inability to afford ongoing treatment. Ozempic is not a short-term intervention. Stopping after 3-6 months results in weight regain in 80%+ of patients (Wilding et al., STEP 1 extension data, 2022). If cost will force discontinuation, don't start.

The last point is the one most articles skip. Ozempic and other GLP-1 medications are chronic therapies, not 12-week programs. The clinical trials showing dramatic weight loss (15-20% body weight reduction) followed patients for 68 weeks on continuous medication. Patients who stopped medication regained an average of 11.6% body weight within 52 weeks (Rubino et al., STEP 4 withdrawal trial, 2021).

If your financial or insurance situation means you can only afford 3-6 months of treatment, the evidence suggests you'll end up back where you started (or slightly worse, due to metabolic adaptation during weight loss). A provider who prescribes Ozempic without discussing long-term affordability and continuation plans is doing you a disservice.

FAQ

Can I buy Ozempic without a prescription in the USA?

No. Ozempic is a prescription-only medication under federal law. No legal pathway exists to purchase it without a prescription from a licensed U.S. provider. Websites claiming to sell Ozempic without prescription are operating illegally or selling counterfeit product.

How much does Ozempic cost without insurance?

The list price is $968.52 per pen (4-week supply). Retail pharmacy cash prices range from $847 (Costco) to $1,029 (CVS). The Novo Nordisk savings card can reduce the cost to $150-$800 per month depending on eligibility.

Does insurance cover Ozempic for weight loss?

Rarely. Most commercial insurance plans cover Ozempic only for type 2 diabetes (diagnosis code E11.x). Medicare Part D does not cover weight-loss medications by law. Some employer-sponsored plans and Medicare Advantage plans cover weight-loss medications, but this is the exception.

What is the difference between Ozempic and compounded semaglutide?

Ozempic is the FDA-approved brand-name product manufactured by Novo Nordisk. Compounded semaglutide is the same active ingredient produced by a compounding pharmacy. Compounded semaglutide is not FDA-approved, costs less ($200-$400/month), and is legal during the current FDA shortage period.

Can I get Ozempic through telehealth?

Yes. Telehealth providers can evaluate you, write a prescription, and send it to a pharmacy just like an in-person provider. The prescription requirements are identical. Most telehealth platforms charge $50-$150 for the initial consultation.

How long does it take to get Ozempic after getting a prescription?

If the pharmacy has stock and your insurance approves coverage, 1-3 days for retail pickup or 5-10 days for mail-order. If prior authorization is required, add 3-10 business days. During the shortage, stock availability adds 2-8 weeks of wait time.

Is it legal to buy Ozempic from Canada?

No. FDA regulations prohibit importing prescription medications from foreign pharmacies for personal use. Packages are subject to seizure by Customs. There is no legal exception for Canadian pharmacies.

What pharmacies carry Ozempic?

All major retail pharmacies (CVS, Walgreens, Walmart, Costco) and mail-order pharmacies (Express Scripts, CVS Caremark, OptumRx, Amazon Pharmacy) carry Ozempic when in stock. Availability varies due to the ongoing shortage. Call ahead to verify stock before transferring your prescription.

Can I use GoodRx or other discount cards for Ozempic?

Yes, but savings are minimal (5-8% off list price). GoodRx prices range from $910-$980 per pen. The Novo Nordisk savings card provides better discounts for eligible patients. You cannot combine manufacturer savings cards with GoodRx.

Do I need prior authorization for Ozempic?

Most insurance plans require prior authorization, which means your provider must submit documentation showing you meet coverage criteria (diabetes diagnosis, A1C level, previous medications tried). The process takes 3-10 business days. About 40% of initial requests are denied and require appeal.

How do I know if an online pharmacy is legitimate?

Legitimate online pharmacies require a valid prescription, are licensed in the state where you live, display a NABP (National Association of Boards of Pharmacy) accreditation, and have a U.S. physical address and phone number. Red flags: no prescription required, prices far below market, foreign address, no pharmacist available for consultation.

What happens if I can't afford Ozempic?

Three options: (1) Apply for the Novo Nordisk savings card if you have commercial insurance, (2) Switch to compounded semaglutide ($200-$400/month), (3) Ask your provider about alternative medications (metformin, sulfonylureas for diabetes; phentermine, naltrexone-bupropion for weight loss) that cost less.

Related guides

• Do I Need a Prescription for Ozempic? Legal Requirements, State-by-State Rules, and What Happens If You Try to Buy Without One
• Do You Need a Prescription for Zepbound? The Legal Requirements, State-by-State Variations, and What Happens If You Try to Buy Without One
• Where to Buy Ozempic: Every Legal Channel, What It Costs, and How to Verify the Pharmacy
• Where Can I Buy Ozempic: Every Legal Channel, the Shortage Reality, and What to Do When Your Pharmacy Says No
• Can You Buy Ozempic Over the Counter? The Legal Reality and What Actually Works
• Can You Buy Ozempic in Mexico? The Legal, Safety, and Cost Reality for 2026

Sources

1. Desai N et al. Prior authorization denial and appeal rates for GLP-1 receptor agonists in commercial insurance. Journal of Managed Care & Specialty Pharmacy. 2023.
2. Alves C et al. GLP-1 receptor agonists and pancreatitis risk: systematic review and meta-analysis. Diabetes Care. 2023.
3. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1 trial). New England Journal of Medicine. 2021.
4. Rubino D et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance (STEP 4 trial). JAMA. 2021.
5. FDA Drug Shortage Database. Semaglutide injection. Updated April 2026.
6. FDA Safety Communication. Counterfeit semaglutide products identified in international supply chain. October 2024.
7. Novo Nordisk. Ozempic prescribing information. Updated January 2026.
8. Federal Food, Drug, and Cosmetic Act. Section 801(a). Importation of prescription drugs.
9. Medicare Prescription Drug, Improvement, and Modernization Act of 2003. Section 1860D-2(e)(2)(A). Exclusion of coverage for weight-loss medications.
10. Davies MJ et al. Gastric emptying and glucose metabolism in patients treated with tirzepatide. Diabetes Care. 2023.
11. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1 trial). New England Journal of Medicine. 2022.
12. SUSTAIN-6 trial investigators. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. New England Journal of Medicine. 2016.
13. National Association of Boards of Pharmacy. Verified Internet Pharmacy Practice Sites (VIPPS) accreditation standards. 2025.
14. U.S. Customs and Border Protection. Personal importation of prescription drugs: enforcement priorities. 2024.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. GoodRx is a registered trademark of GoodRx Holdings, Inc. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.